CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
2 clinical trials · Condition
◉ Watch CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
| Record | Firm | Date |
|---|---|---|
| RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies (NCT06732492) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-10-31 |
| PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies (NCT05170568) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2021-12-01 |
Track CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.